BELLEVUE, WA, June 9 /CNW/ - Oncothyreon Inc. (Nasdaq: ONTY) (TSX: ONY)
(the "Company") today announced that Daniel K. Spiegelman and Stephen K.
Burley, M.D., D.Phil. have joined its board of directors for three-year terms.
The Company also announced the retirement of S. Robert Blair from the board of
directors.